An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleAn Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsDaruka Mahadevan